Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation
- 1Department of Internal Medicine V, Medical University of Innsbruck , , ,
- 2Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Innsbruck , ,
Abstract
Introduction: Recent evidence has demonstrated that both donor- and recipient-derived immune cell subpopulations play a crucial role in various immune responses following allogeneic hematopoietic stem cell transplantation (HSCT). In this retrospective single center analysis, we investigated whether different lymphocyte subpopulations in the bone marrow (BM) of the recipient prior to HSCT might have an impact on outcome parameters after HSCT.
Methods: BM aspirates of 140 patients > 18 years of age receiving a HSCT between 2008 and 2022 were analyzed. BM aspiration was performed within 3 months prior to HSCT. Median time from aspiration to HSCT was 14 days (range 8–104 days). Lymphocyte subpopulations included CD19 ⁺ B cells, CD56 ⁺ NK cells, CD3 ⁺ T cells, CD3 ⁺ CD4 ⁺ T cells, CD3 ⁺ CD8 ⁺ T cells, CD3 ⁺ CD4 ⁻ CD8 ⁻ T cells and CD3 ⁺ CD4 ⁺ CD8 ⁺ T cells.
Results: High total lymphocytes > 37.35% (of leukocytes) correlated with an increased non-relapse mortality (NRM) at day 100 after HSCT, whereas high CD3 ⁺ T cells > 69.45% (of lymphocytes) and CD3 ⁺ CD8 ⁺ T cells > 46.3% were associated with an increased risk for CMV infection. High NK cells > 8.8% resulted in an increased incidence for acute graft-versus host disease (GvHD). High CD19 ⁺ B cells > 13.1% resulted in a decreased incidence of chronic GvHD. In contrast, high CD4 ⁺ T cells > 49.3% were associated with an increased incidence of chronic GvHD.
Conclusion: Recipient-derived lymphocyte subpopulations within the BM prior to HSCT comprise the prognostic potential to assess post-HSCT related outcome parameters. In summary, a shift towards humoral immunity with a BM characterized by a B cell enriched and T cell/NK cell depleted microenvironment appears to be associated with a lower risk for post-HSCT complications.
Related
- T-cell polyfunctionality reconstitution after modified anti-thymocyte globulin plus post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation
- Longitudinal plasma proteome profiling after allogeneic hematopoietic stem cell transplantation: heterogeneous development and associations with acute GvHD
- Impact of prenatal pyrethroid pesticide exposure on neonatal lymphocyte subsets and apoptosis: a birth cohort study.
- Longitudinal trajectories of peripheral blood lymphocyte subsets and PD-1 expression as dynamic prognostic markers in lung cancer
- Case Report: Fulminant aggressive NK-cell leukemia with hemophagocytic lymphohistiocytosis and multiple organ dysfunction successfully bridged to allogeneic hematopoietic stem cell transplantation
BibTeX
@article{koeck2026pretransplant,
title = {{Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation}},
author = {Stefan Koeck and Gabriele Hetzenauer and Josia Fauser and Verena Petzer and Sieghart Sopper and Ines Peschel-Schaar and Dominik Wolf and David Nachbaur and Normann Steiner},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1910059},
url = {https://europepmc.org/article/PMC/PMC13672203},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation
AU - Stefan Koeck
AU - Gabriele Hetzenauer
AU - Josia Fauser
AU - Verena Petzer
AU - Sieghart Sopper
AU - Ines Peschel-Schaar
AU - Dominik Wolf
AU - David Nachbaur
AU - Normann Steiner
PY - 2026
DA - 2026/10/02
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1910059
UR - https://europepmc.org/article/PMC/PMC13672203
AB - Introduction: Recent evidence has demonstrated that both donor- and recipient-derived immune cell subpopulations play a crucial role in various immune responses following allogeneic hematopoietic stem cell transplantation (HSCT). In this retrospective single center analysis, we investigated whether different lymphocyte subpopulations in the bone marrow (BM) of the recipient prior to HSCT might have an impact on outcome parameters after HSCT. Methods: BM aspirates of 140 patients > 18 years of age receiving a HSCT between 2008 and 2022 were analyzed. BM aspiration was performed within 3 months prior to HSCT. Median time from aspiration to HSCT was 14 days (range 8–104 days). Lymphocyte subpopulations included CD19 ⁺ B cells, CD56 ⁺ NK cells, CD3 ⁺ T cells, CD3 ⁺ CD4 ⁺ T cells, CD3 ⁺ CD8 ⁺ T cells, CD3 ⁺ CD4 ⁻ CD8 ⁻ T cells and CD3 ⁺ CD4 ⁺ CD8 ⁺ T cells. Results: High total lymphocytes > 37.35% (of leukocytes) correlated with an increased non-relapse mortality (NRM) at day 100 after HSCT, whereas high CD3 ⁺ T cells > 69.45% (of lymphocytes) and CD3 ⁺ CD8 ⁺ T cells > 46.3% were associated with an increased risk for CMV infection. High NK cells > 8.8% resulted in an increased incidence for acute graft-versus host disease (GvHD). High CD19 ⁺ B cells > 13.1% resulted in a decreased incidence of chronic GvHD. In contrast, high CD4 ⁺ T cells > 49.3% were associated with an increased incidence of chronic GvHD. Conclusion: Recipient-derived lymphocyte subpopulations within the BM prior to HSCT comprise the prognostic potential to assess post-HSCT related outcome parameters. In summary, a shift towards humoral immunity with a BM characterized by a B cell enriched and T cell/NK cell depleted microenvironment appears to be associated with a lower risk for post-HSCT complications.
SN - 1664-3224
ER -